APA (7th ed.) Citation

JK, R., AC, C., BD, B., JP, B., R, S., A, S., . . . PA, N. (2025). Brain cholinergic terminal density utilizing [18F]-fluoroethoxybenzovesamicol PET in adults with Down's syndrome: Relationship to amyloid PET and cognitive performance. Alzheimer's & dementia : the journal of the Alzheimer's Association, 21(4), e70134. https://doi.org/10.1002/alz.70134

Chicago Style (17th ed.) Citation

JK, Russell, et al. "Brain Cholinergic Terminal Density Utilizing [18F]-fluoroethoxybenzovesamicol PET in Adults with Down's Syndrome: Relationship to Amyloid PET and Cognitive Performance." Alzheimer's & Dementia : The Journal of the Alzheimer's Association 21, no. 4 (2025): e70134. https://doi.org/10.1002/alz.70134.

MLA (9th ed.) Citation

JK, Russell, et al. "Brain Cholinergic Terminal Density Utilizing [18F]-fluoroethoxybenzovesamicol PET in Adults with Down's Syndrome: Relationship to Amyloid PET and Cognitive Performance." Alzheimer's & Dementia : The Journal of the Alzheimer's Association, vol. 21, no. 4, 2025, p. e70134, https://doi.org/10.1002/alz.70134.